NDC Package 0023-3670-03 Aczone

Dapsone Gel Topical - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0023-3670-03
Package Description:
15 TUBE in 1 CARTON / 3 g in 1 TUBE
Product Code:
Proprietary Name:
Aczone
Non-Proprietary Name:
Dapsone
Substance Name:
Dapsone
Usage Information:
This medication is used to treat acne. It helps decrease the number and severity of acne pimples and helps pimples that do develop to heal more quickly. Dapsone is an antibiotic. It is not known how dapsone works to treat acne.
11-Digit NDC Billing Format:
00023367003
NDC to RxNorm Crosswalk:
  • RxCUI: 607295 - dapsone 5 % Topical Gel
  • RxCUI: 607295 - dapsone 0.05 MG/MG Topical Gel
  • RxCUI: 701858 - Aczone 5 % Topical Gel
  • RxCUI: 701858 - dapsone 0.05 MG/MG Topical Gel [Aczone]
  • RxCUI: 701858 - Aczone 0.05 MG/MG Topical Gel
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Allergan, Inc.
    Dosage Form:
    Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
    Administration Route(s):
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    NDA021794
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    06-24-2009
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    0023-3670-301 TUBE in 1 CARTON / 30 g in 1 TUBE
    0023-3670-601 TUBE in 1 CARTON / 60 g in 1 TUBE
    0023-3670-901 TUBE in 1 CARTON / 90 g in 1 TUBE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0023-3670-03?

    The NDC Packaged Code 0023-3670-03 is assigned to a package of 15 tube in 1 carton / 3 g in 1 tube of Aczone, a human prescription drug labeled by Allergan, Inc.. The product's dosage form is gel and is administered via topical form.

    Is NDC 0023-3670 included in the NDC Directory?

    Yes, Aczone with product code 0023-3670 is active and included in the NDC Directory. The product was first marketed by Allergan, Inc. on June 24, 2009 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 0023-3670-03?

    The 11-digit format is 00023367003. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20023-3670-035-4-200023-3670-03